Compare PCRX & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | DEA |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | PCRX | DEA |
|---|---|---|
| Price | $23.05 | $23.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $35.33 | $24.99 |
| AVG Volume (30 Days) | ★ 775.3K | 399.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.49% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.21 | $9.69 |
| Revenue Next Year | $8.26 | $7.10 |
| P/E Ratio | ★ $48.25 | $80.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.80 | $19.33 |
| 52 Week High | $27.64 | $29.49 |
| Indicator | PCRX | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 53.39 |
| Support Level | $20.88 | $23.49 |
| Resistance Level | $21.60 | $24.15 |
| Average True Range (ATR) | 0.80 | 0.54 |
| MACD | 0.39 | -0.05 |
| Stochastic Oscillator | 93.52 | 53.10 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.